Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PCMA Makes Specific Rx Cost-Cutting Proposals To Congressional "Super Committee"

This article was originally published in The Pink Sheet Daily

Executive Summary

Many of the proposals will put the PBM industry association at odds with pharmaceutical manufacturers and pharmacies as they try to influence the legislation that will be worked out by the Joint Select Committee on Deficit Reduction over the next three months.
Advertisement

Related Content

Beware The Debt Deal's Spending Cut Trigger: Medicare Part D And B Provider Pay Would Drop
Beware The Debt Deal's Spending Cut Trigger: Medicare Part D And B Provider Pay Would Drop
Brand-Generic "Pay-For-Delay" Settlements Jump 63% In FY 2010
CMS' 2012 Budget Looks To Biosimilars, Ban On Brand/Generic Deals To Offset Costs

Topics

Advertisement
UsernamePublicRestriction

Register

PS072720

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel